戻る
Medigene AG (MDGEF)価格
MDGEF 株価推移チャート
MDGEF 財務
Medigene AG
$2.59
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$2.59
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$2.59
始値
$2.59
当日レンジ
$0.1 - $2.59
52週レンジ
$0.1 - $2.59
取引高
10.0K
平均取引高
0
1株当たり利益(TTM)
-1.28
配当利回り
--
時価総額
$38.1M
MDGEFとは何ですか？
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. The company is headquartered in Planegg, Bayern and currently employs 86 full-time employees. The company went IPO on 2000-06-30. The firm focuses on the development of personalized T cell-based immunotherapies. The company develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The firm operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.